Serum Levels of Anti-Citrullinated Protein Antibody (ACPA) and TWEAK in Patients with Rheumatoid Arthritis: Association with Disease Activity and Treatment Modalities


Creative Commons License

KARKUCAK M. , ÇAPKIN E. , Cakirbay H., Akyuz A., ALVER A. , CANSU A. , ...More

TURKISH JOURNAL OF RHEUMATOLOGY, vol.26, no.3, pp.204-209, 2011 (Journal Indexed in SCI) identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.5606/tjr.2011.032
  • Title of Journal : TURKISH JOURNAL OF RHEUMATOLOGY
  • Page Numbers: pp.204-209

Abstract

Objectives: In this study, we evaluated the serum levels of a serum TNF-related weak inducer of apoptosis (TWEAK) and anti-citrullinated protein antibody (ACPA) and investigated the possible correlation of these parameters with disease activity, cytokine levels and anti-TNF-alpha treatment in patients with rheumatoid arthritis (RA).